デフォルト表紙
市場調査レポート
商品コード
1614174

エレクトロポレーション機器市場:用途別、エンドユーザー別-2025-2030年の世界予測

Electroporation Instrument Market by Application (Biomedical Research, Protein Production), End-user (Academic & Research Institutions, Pharmaceutical & Biotechnology Companies) - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 184 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
エレクトロポレーション機器市場:用途別、エンドユーザー別-2025-2030年の世界予測
出版日: 2024年12月01日
発行: 360iResearch
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

エレクトロポレーション機器市場は、2023年に2億6,706万米ドルと評価され、2024年には2億8,100万米ドルに達すると予測され、CAGR 5.49%で成長し、2030年には3億8,844万米ドルになると予測されています。

エレクトロポレーション器具は、電気的に誘導される細胞膜の穿孔によって細胞透過性を高め、薬物、タンパク質、ヌクレオチドなどの物質の細胞内への直接導入を容易にする上で極めて重要です。これらの器具の必要性は、遺伝子工学、がん治療、ワクチン開発、遺伝子治療における重要な応用に由来します。特に、正確な遺伝子編集が最も重要な臨床研究とバイオ医薬品生産において重要な役割を果たしています。最終用途の範囲には、学術研究機関、バイオテクノロジー企業、高度な治療・診断用途に重点を置く病院が主に含まれます。市場開拓の主な原動力は、研究開発資金の増加、標的治療薬に対する需要の急増、送達効率と安全性を高める技術の進歩です。しかし、エレクトロポレーション・システムが高価であること、技術的な専門知識が必要であること、競合製品間の差別化が限定的であることなどの課題が、実質的な制約となっています。さらに、臨床応用における規制上のハードルは、製品の承認や市場浸透を遅らせる可能性があります。このような課題にもかかわらず、エレクトロポレーションによって治療効果を大幅に高めることができる個別化医療や免疫療法の分野には、潜在的な機会があふれています。マイクロ流体工学やナノテクノロジーとエレクトロポレーションとの融合は、技術革新のための広大な道を提示し、コストを削減し、細胞送達プロセスの精度を高める可能性があります。パルシング・パラメーターの最適化と多機能デバイスの開発に焦点を当てた探索的研究は、市場の魅力をさらに高めることができます。市場の持続的な成功は、イノベーションを促進するための学術・商業部門を超えた協力関係の育成にかかっています。市場は競争が激しく技術主導型であるため、進行中の進歩、規制環境、消費者の考察を常に把握することが極めて重要です。品質、コスト、イノベーションのバランスを取ることができる企業は、ダイナミックに進化するこの市場で競争力を獲得できると思われます。

主な市場の統計
基準年[2023] 2億6,706万米ドル
予測年[2024] 2億8,100万米ドル
予測年[2030] 3億8,844万米ドル
CAGR(%) 5.49%

市場力学:急速に進化するエレクトロポレーション機器市場の主要市場インサイトを公開

エレクトロポレーション機器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • がんおよびその他の遺伝性疾患の有病率の増加
    • 製薬業界におけるモノクローナル抗体の新たな応用
    • エレクトロポレーションを用いたワクチン送達システムの開発
    • 個別化医療の重視の高まり
  • 市場抑制要因
    • エレクトロポレーション機器に関連する高コスト
  • 市場機会
    • エレクトロポレーション技術の技術的進歩
    • 製薬会社やバイオテクノロジー企業からの投資の増加
  • 市場の課題
    • 潜在的な細胞損傷と分子の非特異的輸送に関する懸念

ポーターのファイブフォース:エレクトロポレーション機器市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:エレクトロポレーション機器市場における外部からの影響の把握

外部マクロ環境要因は、エレクトロポレーション機器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析エレクトロポレーション機器市場における競合情勢の把握

エレクトロポレーション機器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスエレクトロポレーション機器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、エレクトロポレーション機器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨エレクトロポレーション機器市場における成功への道筋を描く

エレクトロポレーション機器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • がんやその他の遺伝性疾患の罹患率の増加
      • 医薬品業界におけるモノクローナル抗体の新たな応用
      • 電気穿孔法を用いたワクチン送達システムの開発
      • 個別化医療への重点の高まり
    • 抑制要因
      • 電気穿孔装置に関連する高コスト
    • 機会
      • 電気穿孔法の技術的進歩
      • 製薬企業とバイオテクノロジー企業からの投資増加
    • 課題
      • 潜在的な細胞損傷と分子の非特異的輸送に関する懸念
  • 市場セグメンテーション分析
    • アプリケーション:慢性疾患の増加により、バイオメディカル調査における電気穿孔装置の利用が促進される
    • エンドユーザー:製薬会社やバイオテクノロジー会社は、より精度と拡張性に優れたエレクトロポレーション機器を好みます。
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 エレクトロポレーション機器市場:用途別

  • 生物調査
  • タンパク質生産

第7章 エレクトロポレーション機器市場:エンドユーザー別

  • 学術・調査機関
  • 製薬・バイオテクノロジー企業

第8章 南北アメリカのエレクトロポレーション機器市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のエレクトロポレーション機器市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのエレクトロポレーション機器市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • MaxCyte、患者のための次世代遺伝子編集治療を推進するため、プライムメディシンと戦略的プラットフォームライセンスを締結
  • 戦略分析と提言

企業一覧

  • ALA Scientific Instruments, Inc.
  • Bertin Technologies SAS
  • Bio-Rad Laboratories, Inc.
  • BTX by Harvard Bioscience, Inc.
  • Celetrix, LLC
  • Eppendorf SE
  • Inovio Pharmaceuticals Inc.
  • Lonza Group Ltd.
  • MaxCyte, Inc.
  • Mirus Bio LLC
  • Thermo Fisher Scientific Inc.
図表

LIST OF FIGURES

  • FIGURE 1. ELECTROPORATION INSTRUMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ELECTROPORATION INSTRUMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ELECTROPORATION INSTRUMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ELECTROPORATION INSTRUMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ELECTROPORATION INSTRUMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ELECTROPORATION INSTRUMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ELECTROPORATION INSTRUMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ELECTROPORATION INSTRUMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY BIOMEDICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PROTEIN PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ELECTROPORATION INSTRUMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ELECTROPORATION INSTRUMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM ELECTROPORATION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM ELECTROPORATION INSTRUMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ELECTROPORATION INSTRUMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. ELECTROPORATION INSTRUMENT MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-E1122A48A8B0

The Electroporation Instrument Market was valued at USD 267.06 million in 2023, expected to reach USD 281.00 million in 2024, and is projected to grow at a CAGR of 5.49%, to USD 388.44 million by 2030.

Electroporation instruments are pivotal in enhancing cellular permeability through electrically induced cell membrane poration, facilitating the introduction of substances like drugs, proteins, or nucleotides directly into cells. The necessity of these instruments stems from their crucial application in genetic engineering, cancer treatment, vaccine development, and gene therapy. In particular, they play a significant role in clinical research and biopharmaceutical production, where precise gene editing is paramount. The end-use scope predominantly encompasses academic research institutions, biotechnology firms, and hospitals focusing on advanced therapeutic and diagnostic applications. Market growth is primarily driven by increased funding in research and development, burgeoning demand for targeted therapeutics, and technological advancements enhancing delivery efficiency and safety. However, challenges such as the high cost of electroporation systems, technical expertise requirement, and limited differentiability between competing products pose substantial limitations. Additionally, regulatory hurdles in clinical applications can slow down product approvals and market penetration. Despite these challenges, potential opportunities abound in the expanding field of personalized medicine and immunotherapy, where electroporation can significantly enhance treatment efficacy. The integration of microfluidics and nanotechnology with electroporation presents vast avenues for innovation, potentially reducing costs and increasing precision in cellular delivery processes. Explorative research focusing on optimizing pulsing parameters and developing multifunctional devices can further augment market appeal. Sustainable market success hinges on fostering collaborations across academic and commercial sectors to expedite innovation. As the market is highly competitive and technologically driven, keeping abreast with ongoing advancements, regulatory environments, and consumer insights is crucial. Companies that can balance quality, cost, and innovation are likely to garner a competitive edge in this dynamically evolving market.

KEY MARKET STATISTICS
Base Year [2023] USD 267.06 million
Estimated Year [2024] USD 281.00 million
Forecast Year [2030] USD 388.44 million
CAGR (%) 5.49%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Electroporation Instrument Market

The Electroporation Instrument Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of cancer and other genetic disorders
    • Emerging applications of monoclonal antibodies in pharmaceutical industries
    • Development in vaccine delivery system using electroporation
    • Growing emphasis on personalized medicine
  • Market Restraints
    • High cost associated with electroporation instruments
  • Market Opportunities
    • Technological advancements of electroporation techniques
    • Rising investments from pharmaceutical and biotech companies
  • Market Challenges
    • Concern associated with potential cell damage and the nonspecific transport of molecules

Porter's Five Forces: A Strategic Tool for Navigating the Electroporation Instrument Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Electroporation Instrument Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Electroporation Instrument Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Electroporation Instrument Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Electroporation Instrument Market

A detailed market share analysis in the Electroporation Instrument Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Electroporation Instrument Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Electroporation Instrument Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Electroporation Instrument Market

A strategic analysis of the Electroporation Instrument Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Electroporation Instrument Market, highlighting leading vendors and their innovative profiles. These include ALA Scientific Instruments, Inc., Bertin Technologies SAS, Bio-Rad Laboratories, Inc., BTX by Harvard Bioscience, Inc., Celetrix, LLC, Eppendorf SE, Inovio Pharmaceuticals Inc., Lonza Group Ltd., MaxCyte, Inc., Mirus Bio LLC, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Electroporation Instrument Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Application, market is studied across Biomedical Research and Protein Production.
  • Based on End-user, market is studied across Academic & Research Institutions and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cancer and other genetic disorders
      • 5.1.1.2. Emerging applications of monoclonal antibodies in pharmaceutical industries
      • 5.1.1.3. Development in vaccine delivery system using electroporation
      • 5.1.1.4. Growing emphasis on personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with electroporation instruments
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements of electroporation techniques
      • 5.1.3.2. Rising investments from pharmaceutical and biotech companies
    • 5.1.4. Challenges
      • 5.1.4.1. Concern associated with potential cell damage and the nonspecific transport of molecules
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Application: Growing prevalence of chronic disorder boost the utilization of electroporation iInstrument in biomedical research
    • 5.2.2. End-user: Pharmaceutical & biotechnology companies prefer electroporation instrument with more precision & scalability
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Electroporation Instrument Market, by Application

  • 6.1. Introduction
  • 6.2. Biomedical Research
  • 6.3. Protein Production

7. Electroporation Instrument Market, by End-user

  • 7.1. Introduction
  • 7.2. Academic & Research Institutions
  • 7.3. Pharmaceutical & Biotechnology Companies

8. Americas Electroporation Instrument Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Electroporation Instrument Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Electroporation Instrument Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. MaxCyte Signs Strategic Platform License with Prime Medicine to Advance Next-Generation Gene Editing Therapies for Patients
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ALA Scientific Instruments, Inc.
  • 2. Bertin Technologies SAS
  • 3. Bio-Rad Laboratories, Inc.
  • 4. BTX by Harvard Bioscience, Inc.
  • 5. Celetrix, LLC
  • 6. Eppendorf SE
  • 7. Inovio Pharmaceuticals Inc.
  • 8. Lonza Group Ltd.
  • 9. MaxCyte, Inc.
  • 10. Mirus Bio LLC
  • 11. Thermo Fisher Scientific Inc.